https://www.selleckchem.com/products/tl12-186.html
Prevalence estimates of the serious pathology categories were reported. A total of 1568704 courses of treatment were included in the analysis. The overall prevalence of serious pathology was 2.30%. The prevalence of neoplasm was 2.11%, cauda equina syndrome 0.01%, fractures 0.13%, infections 0.01% and inflammatory pathology 0.06%. Higher prevalence's were observed among patients with a previous history of serious pathology, aged above 50 and with comorbidites. Although serious pathology among patients referred by the General Practition